The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering Pharmalink in 2022.
The AFDO/RAPS Healthcare Products Collaborative pharmaceutical community consists of global regulators and industry thought leaders working to address complex challenges with scientifically sound, defensible, and unbiased forums and training to support the advancement of innovation for the betterment of patients around the world.
At PharmaLink, we work to find solutions that will increase confidence in product quality throughout your products’ life cycle management and global supply chain. We do this by aligning with the strategic priorities of the FDA and industry — and by helping participants create network links to drive compliant innovations. The solutions might not be evident within our companies, or our industry, so we explore beyond our industry — beyond borders and beyond comfort zones.
